| NOVARTIS N | 92.77 / +0.05% |
| Date/Time | 01/21 / 12:35 |
| Chg. / Chg.(%) | 0.05 / +0.05% |
| Bid | 92.75 / 904 |
| Ask | 92.77 / 538 |
| Open | 92.47 |
| Previous Close | 92.72 |
| High | 92.89 |
| Low | 92.40 |
| Volume [CHF] | 81,077,805.89 |
| Volume [Units] | 996,276 |
| Price fixings | 4151 |
| ISIN | CH0012005267 |
| Security | NOVN |
| Exchange | SIX Swiss Exchange |
| Type | Stock |
| Exchange | Last | Volume | |
|---|---|---|---|
| SIX Swiss Ex.. | 92.77 |  |
996,276 |
| London Inter.. | 92.77 | |
22,679 |
| Lang & Schwa.. | 86.120 | |
|
| Nasdaq Other.. | 95.2000 | |
747 |
| Cboe Europe .. | 89.12 | 520,892 | |
| Turquoise | 89.12 | |
146,333 |
| TradeGate | 80.000 | 16,350 | |
| Frankfurt | 80.1600 | 1,589 | |
| Borsa Italia.. | 79.20 | 1,042 | |
| Hamburg | 80.19 | 1,000 | |
| Turquoise | 80.28 | |
125 |
| München | 80.10 | 55 | |
| Berlin | 80.40 | 40 | |
| gettex | 80.160 | 20 | |
| Düsseldorf | 80.18 | 4 | |
| Hannover | 80.10 | 0 | |
| Borsa Italia.. | 75.00 | 36 | |
| EUREX | Options | ||
News
- Genmab Announces European Marketing Authorization for DARZALEX® (Daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone in Frontline Multiple Myeloma
01/20/2020 / 18:02 - GlobeNewswire - Novartis nears deal to acquire Medicines - report
11/23/2019 / 20:54 - TeleTrader - Novartis' net sales up 10% to $12.17B in Q3
10/22/2019 / 07:03 - TeleTrader - ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Novartis AG and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
09/25/2019 / 17:20 - GlobeNewswire - SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Novartis AG
09/23/2019 / 16:23 - GlobeNewswire
Real-time